Theralase Technologies (TSXV:TLT) Pre-Tax Income : C$-4.33 Mil (TTM As of Sep. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Theralase Technologies Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Theralase Technologies's pretax income for the three months ended in Sep. 2024 was C$-0.94 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was C$-4.33 Mil. Theralase Technologies's pretax margin was -270.32%.

During the past 13 years, Theralase Technologies's highest Pretax Margin was -187.40%. The lowest was -769.09%. And the median was -347.48%.

Theralase Technologies Pre-Tax Income Historical Data

The historical data trend for Theralase Technologies's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Pre-Tax Income Chart

Theralase Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-7.41

-5.60

-4.41

-5.24

-4.57

Theralase Technologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Pre-Tax Income	Get a 7-Day Free Trial															-1.02	-0.99	-1.27	-1.13	-0.94

Competitive Comparison of Theralase Technologies's Pre-Tax Income

For the Medical Devices subindustry, Theralase Technologies's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theralase Technologies's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Pre-Tax Income falls into.

Theralase Technologies Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Theralase Technologies's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-4.594	+	0.004	+	-0.03	+	0.05	+	-0.00099999999999856
	=	-4.57

Theralase Technologies's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.949	+	0.001	+	-0.006	+	0.017	+	-0.001
	=	-0.94

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-4.33 Mil.

Theralase Technologies (TSXV:TLT) Pre-Tax Income Explanation

Theralase Technologies's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.938	/	0.347
	=	-270.32%

During the past 13 years, Theralase Technologies's highest Pretax Margin was -187.40%. The lowest was -769.09%. And the median was -347.48%.

Theralase Technologies Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (TSXV:TLT) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

TLTFF:USA TTX:Germany TTX:Germany

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

Executives

Matthew Thomas Perraton	Director
Roger John Dumoulin-white	10% Security Holder, Director, Senior Officer
Kristina Maria Hachey	Senior Officer
Arkady Mandel	Senior Officer
Guy John Anderson	Director
Shawn Shirazi	Senior Officer